Bringing doctors together

or

A free, private network for verified physicians

  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Biologic Heterogeneity May Further Refine Axillary Risk After Neoadjuvant Therapy.

    Nov 10, 2026DOI: 10.1245/s10434-026-20883-yLetterASO

    Written by: Rajika JindaniMaureen McEvoy

    Full abstract not available! Read the article on the external site for details.

    AOAnnals of Surgical Oncology

    Annals of Surgical Oncology

    Official Account
    https://surgonc.org/annals-of-surgical-oncology/
    aso